McDermott Will & Schulte advises Amulet Capital Partners on acquisition of TFP Fertility Group

Global law firm McDermott Will & Schulte represented Amulet Capital Partners (“Amulet”), a middle-market private equity investment firm focused exclusively on the healthcare sector, in its acquisition of TFP Fertility Group, one of the leading fertility care providers in the UK and Northern Europe, from Benefit Street Partners (BSP) – a Franklin Templeton company.

The deal was announced on May 7, and financial terms of the transaction were not disclosed.

This investment underscores Amulet’s commitment to supporting providers that deliver high-quality, patient-centered care.

Together, Amulet and TFP will focus on expanding access, enhancing the patient experience, and building on the company’s position as a leading provider across the company’s core markets.

The McDermott team was led by Kristian Werling, Ellie West and Jamie Burgess with invaluable assistance from Nikita Panchal, Tom Johnson, Elizabeth Spencer, Mark Fine, Giulia Venanzoni, Sharon Lamb, William Gibson-Dancer, Bethany Drayton, Alex Jupp, Hannah Guest, Devina Rana, Catherine MacDonald, Jarrett Szczesny, Bella North, Andrew Granek, Kevin Hall, Michael Bruno, Joel Rush, Eric Preston and Rosemary Tulloch.

About McDermott’s Cross-Border Healthcare PE Capabilities

With more than 150 private equity-focused lawyers working across offices globally, McDermott Will & Schulte is poised to help clients stay ahead of the curve on all types of PE transactions – including fund formation, mergers and acquisitions, minority and majority investments, and leveraged buyouts.

The firm brings deep experience advising private equity sponsors and investors in healthcare and life sciences, supported by the cross-border and cross-practice capabilities critical to executing complex healthcare deals across jurisdictions.

Its internationally recognised Health and Life Sciences practice helps clients drive innovative transactions and navigate high-stakes disputes, enforcement risks, and complex regulatory issues across the healthcare ecosystem, including health systems and other providers, payors, private equity and other investors, major healthcare and life sciences companies, health technology developers, and new market entrants.

McDermott is the only healthcare practice to receive top rankings from Pitchbook, Best Law Firms, Chambers, Legal 500, and Law360, and we also rank among the leading life sciences law firms.

Find out more about McDermott at mcdermottlaw.com